The phosphodiesterase 5 inhibitor sildenafil stimulates angiogenesis through a protein kinase G/MAPK pathway

Journal of Cellular Physiology

Volumn 211, Issue 1, 2007, Pages 197-204

  Pyriochou, Anastasia ^a   Zhou, Zongmin ^b   Koika, Vasiliki ^a   Petrou, Christos ^a   Cordopatis, Paul ^c   Sessa, William C ^c   Papapetropoulos, Andreas ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; CHORIOALLANTOIC MEMBRANE; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SOLUBILITY; SULFONES;

EID: 33847612871     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20929     Document Type: Article

References (45)

1. Bernatowitz MS, Daniels SB, Koster H. 1989. A comparison of acid labile linkage agents for the synthesis of peptide C-terminal amides. Tetrahedron Lett 30:4645-4648.
2. Carmeliet P. 2003. Angiogenesis in health and disease. Nat Med 9:653-660.
3. Carpino LA, Han GY. 1970. 9-Fluorenylmethoxycarbonyl function, a new base-sensitive amino-protecting group. J Am Chem Soc 92:5748-5749.
4. Conway EM, Collen D, Carmeliet P. 2001. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507-521.
5. Dostmann WRG, Taylor MS, Nickl CK, Brayden JE, Frank R, Tegge WJ. 2000. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase 1alpha inhibit NO-induced cerebral dilation. Proc Natl Acad Sci USA 97:14772-14777.
6. Draijer R, Vaandrager AB, Nolte C, de Jonge HR, Walter U, van Hinsbergh VWM. 1995. Expression of cGMP-dependent protein kinase 1 and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 77:897-905.
7. Essayan DM. 2001. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 108:671-680.
8. Favot L, Keravis T, Holl V, Le Bec A, Lugnier C. 2003. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thromb Haemost 90:334-343.
9. Ferrara N, Kerbel R. 2005. Angiogenesis as a therapeutic target. Nature 438:967-974.
10. Folkman J, Shing Y. 1992. Angiogenesis. J Biol Chem 267:10931-10934.
11. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun C-O, Buerk DG, Huang PL, Jain RK. 2001. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98:2604-2609.
12. Hood J, Granger HJ. 1998. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem 273:23504-23508.
13. Isenberg JS, Ridnour LA, Perruccio EM, Espey MG, Wink DA, Roberts DD. 2005. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci USA 102:13141-13146.
14. Itoh H, Pratt R, Dzau V. 1992. Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells. Hypertension 19:758-761.
15. Jain R. 2003. Molecular regulation of vessel maturation. Nature 9:685-693.
16. Kawasaki K, Smith RS, Jr., Hsieh C-M, Sun J, Chao J, Liao JK. 2003. Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis. Mol Cell Biol 23:5726-5737.
17. Keravis TK, Lugnier Claire N. 2000. Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: Differential regulation in cobblestone and spindle phenotypes. J Vasc Res 37:235-249.
18. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, Thebaud B. 2005. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172:750-756.
19. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, Waldman SA. 2000. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52:375-414.
20. McMullen M, Keller R, Sussman M, Pumiglia K. 2004. Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene 23:1275-1282.
21. McMullen ME, Bryant PW, Glembotski CC, Vincent PA, Pumiglia KM. 2005. Activation of p38 has opposing effects on the proliferation and migration of endothelial cells. J Biol Chem 280:20995-21003.
22. Miro X, Casacuberta JM, Gutierrez-Lopez MD, de Landazuri MO, Puigdomenech P. 2000. Phosphodiesterases 4D and 7A splice variants in the response of HUVEC cells to TNF-[alpha]1. Biochem Biophys Res Commun 274:415-421.
23. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. 1996. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Phys 270:H411-H415.
24. Morbidelli L, Donnini S, Ziche M. 2003. Role of nitric oxide in the modulation of angiogenesis. Curr Pharm Des 9:521-530.
25. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, Huang PL, Isner JM. 1998. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567-2578.
26. Netherton SJ, Maurice DH. 2005. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: Implications in angiogenesis. Mol Pharmacol 67:263-272.
27. Oliveira CJR, Schindler F, Ventura AM, Morais MS, Arai RJ, Debbas V, Stern A, Monteiro HP. 2003. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic Biol Med 35:381-396.
28. Papapetropoulos A, Desai KM, Rudic RD, Mayer B, Zhang R, Ruiz-Torres MP, Garcia-Cardena G, Madri JA, Sessa WC. 1997a. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta1-stimulated capillary organization in vitro. Am J Pathol 150:1835-1844.
29. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC. 1997b. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100:3131-3139.
30. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F, Ziche M. 1998. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273:4220-4226.
31. Pedram A, Razandi M, Hu R-M, Levin ER. 1997. Vasoactive peptides modulate vascular endothelial cell growth, factor production and endothelial cell proliferation and invasion. J Biol Chem 272:17097-17103.
32. Pedram A, Razandi M, Levin ER. 2001. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology 142:1578-1586.
33. Pyriochou A, Beis D, Koika V, Polytarchou C, Papadimitriou E, Zhou Z, Papapetropoulos A. 2006. Soluble guanylyl cyclase activation promotes angiogenesis. J Pharmacol Exp Ther 319:663-671.
34. Ridnour LA, Isenberg JS, Espey MG, Thomas DD, Roberts DD, Wink DA. 2005. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 102:13147-13152.
35. Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA. 2003. Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93:280-291.
36. Sadhu K, Hensley K, Florio VA, Wolda SL. 1999. Differential expression of the cyclic GMP-stimulated phosphodiesterase PDE2A in human venous and capillary endothetial cells. J Histochem Cytochem 47:895-906.
37. Seger R, Krebs E. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
38. Tas A, Atasoy N, Ozbek H, Aslan L, Yuksel H, Ceylan E, Dagoglu G. 2003. The effects of sildenafil citrate (Viagra) in the early phase of healing process in open wounds in dogs. Acta Vet BRNO 72:273-277.
39. Thompson WJ, Ashikaga T, Kelly JJ, Liu L, Zhu B, Vemavarapu L, Strada SJ. 2002. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). Biochem Pharmacol 63:797-807.
40. Vidavalur R, Penumathsa SV, Zhan L, Thirunavukkarasu M, Maulik N. 2006. Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor. Vasc Pharmacol 45:91-95.
41. Yamahara K, Itoh H, Chun T-H, Ogawa Y, Yamashita J, Sawada N, Fukunaga Y, Sone M, Yurugi-Kobayashi T, Miyashita K, Tsujimoto H, Kook H, Feil R, Garbers DL, Hofmann F, Nakao K. 2003. Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci USA 100:3404-3409.
42. Zachary I. 2003. VEGF signalling: Integration and multi-tasking in endothelial cell biology. Biochem Soc Trans 31:1171-1177.
43. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z, Chopp M. 2003. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 92:308-313.
44. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F. 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044.
45. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R. 1997. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625-2634.